MedTrace Logo

Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics

NCT06780267 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2025-11-18

No results posted yet for this study

Summary

The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for Postoperative analgesia in orthopaedics. To explore the reasonable dosage of HRS-2129 for Postoperative analgesia in orthopaedics.

Conditions

  • Postoperative Pain in Orthopaedics

Interventions

DRUG

HRS-2129

HRS-2129

DRUG

HRS-2129 placebo

HRS-2129 placebo

DRUG

Tramadol Hydrochloride SR Tablets

Tramadol Hydrochloride SR Tablets

Sponsors & Collaborators

  • Shandong Suncadia Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-11
Primary Completion
2026-01-31
Completion
2026-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06780267 on ClinicalTrials.gov